ANRO
Alto Neuroscience, Inc.
24.80$
-2.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | -3.2% | +5.4% | +3.1% | +100.0% | -15.0% | +0.6% | -41.5% | +64.0% | -4.3% | +17.2% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +21.0% | +3.2% | +32.5% | -0.9% | -17.3% | -7.6% | +31.6% | -19.8% | +14.0% | +69.2% | +8.9% | – | |
| – | +21.2% | +109.0% | +16.3% | +13.0% | +6.4% | -8.0% | -2.5% | -20.4% | +14.3% | +35.3% | +2.6% | – | |
| – | +20.1% | +22.4% | +28.4% | +3.0% | -10.9% | -6.8% | +18.5% | -19.5% | -873.7% | – | +8.1% | – | |
| – | – | – | – | – | – | – | – | – | – | -123.5% | – | – | |
| – | -1.9% | -2.8% | +0.3% | +0.6% | -4.6% | +79.6% | +8.0% | +0.6% | -11.5% | -5.2% | -9.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -200.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.